title: Pioglitazone: Hype and hope.
authors.affiliation: Department of Endocrinology, King Edward Memorial Hospital, Mumbai, Maharashtra, India.
authors.forename: S S
authors.initials: SS
authors.lastname: Jadhav
authors.forename: V K
authors.initials: VK
authors.lastname: Shivane
authors.forename: A R
authors.initials: AR
authors.lastname: Lila
authors.forename: T R
authors.initials: TR
authors.lastname: Bandgar
authors.forename: N S
authors.initials: NS
authors.lastname: Shah
mesh_terms: D044466:Asian People; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000208:ethnology; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007194:India; D007333:Insulin Resistance / Q000208:ethnology; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone